Cantor Fitzgerald Starts TherapeuticsMD (TXMD) at Overweight
Tweet
Share
E-mail
Get Alerts TXMD Hot Sheet
Price: $1.92 +2.13%
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Cantor Fitzgerald initiated coverage on TherapeuticsMD (NYSE: TXMD) with an Overweight rating and a price target of $34.00.
For an analyst ratings summary and ratings history on TherapeuticsMD click here. For more ratings news on TherapeuticsMD click here.
Shares of TherapeuticsMD closed at $5.54 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
- Craig-Hallum Assumes DiaMedica Therapeutics Inc. (DMAC) at Buy
- JPMorgan Starts IDFC First Bank Ltd (IDFCFB:IN) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
